Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 08:00 save search
HRT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that HireRight Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-04-10 (Crawled : 08:00) - prnewswire.com
LUNA | $2.82 2.17% 2.13% 620K
|
Electronic Technology
|
| O: -0.7%
H: 0.0%
C: -1.4%
CKPT | $1.595 -4.49% -4.7% 470K
|
Health Technology
|
| O: -1.64%
H: 1.67%
C: -1.11%
corporation
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
RLFTF | $1.43 2.14% 11.45% 3.8K
|
n/a
|
| O: -3.07%
H: 18.31%
C: 12.54%
ETON | $3.06 -2.55% -0.64% 69K
|
Health Technology
|
| O: 6.08%
H: 5.73%
C: 3.13%
license pharmaceuticals golike therapeutics agreement
Novo Holdings Joins €30M Series A Financing for Asgard Therapeutics, Leader In In Vivo Cell Reprogramming To Treat Cancer
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
cancer treat series cell
Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
million series cell therapeutics platform
Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO®
Published: 2024-03-06 (Crawled : 08:00) - prnewswire.com
CALT | News | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: 13.42%
H: 0.22%
C: -4.35%
tarpeyo drug year
AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published: 2024-03-05 (Crawled : 08:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
lung drug cancer treatment application therapeutics
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)
Published: 2024-02-13 (Crawled : 08:00) - globenewswire.com
VRTX | News | $393.51 0.1% 0.1% 950K
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -0.32%
CRSP M | $56.16 1.08% 1.03% 1.6M
|
Health Technology
|
| O: -5.3%
H: 3.85%
C: 0.54%
first disease cell treatment
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.09%
H: 0.39%
C: -0.36%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.43%
H: 0.67%
C: 0.21%
BAX | $39.65 0.33% -1.19% 2.3M
|
Health Technology
|
| O: 0.21%
H: 0.24%
C: -1.04%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
BMRN S | $90.07 -0.44% -0.43% 780K
|
Health Technology
|
| O: -0.38%
H: 1.79%
C: 0.22%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -0.4%
H: 0.19%
C: -0.33%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -6.22%
america therapeutics growth market
Sleep Apnea Diagnostic and Therapeutic Devices Market size to grow by USD 3.29 billion from 2022 to 2027; The increasing early detection of sleep apnea disorders to boost the market- Technavio
Published: 2024-01-16 (Crawled : 08:00) - prnewswire.com
RMD | $177.61 2.18% 0.01% 1.6M
|
Health Technology
|
| O: -1.26%
H: 0.19%
C: -0.87%
PHG | $19.98 -0.84% 0.0% 500K
|
Health Technology
|
| O: -1.96%
H: 0.21%
C: -0.51%
diagnostic disorders market
Calliditas Therapeutics provides business update ahead of JP Morgan conference
Published: 2024-01-08 (Crawled : 08:00) - prnewswire.com
CALT | News | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: 2.68%
H: 3.22%
C: 0.35%
conference business update therapeutics
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report
Published: 2024-01-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -0.85%
H: 1.05%
C: 0.08%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
ALPMY | $9.47 0.11% -1.11% 520K
|
Manufacturing
|
| O: 0.53%
H: 3.97%
C: 0.45%
CLVT | $6.95 0.58% 0.0% 6.2M
|
Information
|
| O: 0.92%
H: 6.4%
C: 5.03%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.63%
H: 0.58%
C: 0.58%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
CALT | News | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: 2.68%
H: 3.22%
C: 0.35%
report potential
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published: 2023-12-12 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.56%
H: 0.51%
C: 0.51%
ALPMY | $9.47 0.11% -1.11% 520K
|
Manufacturing
|
| O: -5.13%
H: 5.41%
C: 3.46%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.45%
H: 0.75%
C: 0.46%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.18%
H: 0.43%
C: 0.25%
GBIO | $2.78 -6.71% -7.39% 200K
|
Health Technology
|
| O: 5.62%
H: 3.72%
C: -4.26%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.59%
H: 1.35%
C: 0.6%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: 1.83%
H: 0.04%
C: -1.13%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -0.46%
H: 5.56%
C: -1.12%
ABEO | $7.53 -5.04% -5.03% 250K
|
Health Technology
|
| O: 0.65%
H: 2.59%
C: 0.86%
america therapy growth market
Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
Published: 2023-12-08 (Crawled : 08:00) - biospace.com/
MCRB | $0.5842 -6.87% -6.5% 3.6M
|
Health Technology
|
| O: 2.73%
H: 3.54%
C: -3.54%
ser-155 presentation therapeutics
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: 3.87%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
ALPMY | $9.47 0.11% -1.11% 520K
|
Manufacturing
|
| O: -3.37%
H: 4.51%
C: 4.51%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.25%
H: 0.68%
C: 0.48%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
GBIO | $2.78 -6.71% -7.39% 200K
|
Health Technology
|
| O: 0.0%
H: 38.05%
C: 23.01%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.06%
H: 0.35%
C: 0.29%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: 0.92%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -5.76%
H: 16.36%
C: 15.07%
ABEO | $7.53 -5.04% -5.03% 250K
|
Health Technology
|
| O: -2.43%
H: 0.0%
C: 0.0%
research growing therapy market
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
Published: 2023-11-30 (Crawled : 08:00) - globenewswire.com
CYCN | $3.315 3.01% 12.62% 180
|
Health Technology
|
| O: 6.88%
H: 40.77%
C: 6.72%
company builder
Sobi to present new data at ASH 2023 Annual Meeting
Published: 2023-11-20 (Crawled : 08:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.77%
H: 0.0%
C: 0.0%
ADCT | $4.76 -4.03% -0.84% 280K
|
Health Technology
|
| O: 6.58%
H: 0.01%
C: -5.28%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
meeting
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
Published: 2023-11-07 (Crawled : 08:00) - biospace.com/
EVO | News | $7.15 -1.24% -0.7% 27K
|
Manufacturing
|
| O: -4.51%
H: 3.61%
C: 2.84%
partnership pipeline therapeutics
Medical Aesthetics Market 2023-2027 | The increased emphasis on fat-loss treatments is the market trend- Technavio
Published: 2023-11-03 (Crawled : 08:00) - prnewswire.com
ANIK | News | $25.43 -1.01% -0.9% 83K
|
Health Technology
|
| O: 27.49%
H: 0.17%
C: -12.76%
medical market
Biotechnology reagents market size to increase by USD 36.01 billion | the high usage of biotechnology reagents in diagnostic and therapeutic applications drives market growth- Technavio
Published: 2023-10-27 (Crawled : 08:00) - prnewswire.com
TMO | News | $541.52 -1.05% -0.1% 1.8M
|
Health Technology
|
| O: 2.03%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 1.57%
H: 0.6%
C: -2.01%
diagnostic market
New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
CALT | News | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: 2.58%
H: 0.08%
C: -3.42%
nefecon nephropathy drug approval treatment application
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.